Clinical Aspects of Fatty Liver Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

The global emergence of obesity as an epidemic has made fatty liver disease a public health problem in the Western world. The increased incidence of obesity has been paralleled by an increase in metabolic syndrome in the same cohort of patients. The net consequence of insulin resistance in a large majority of these obese individuals is hepatic steatosis, which over time in a proportion of these patients progresses to steatohepatitis and cirrhosis. Despite the increased awareness among physicians regarding its presence, the diagnostic process has been hampered by the lack of sensitive and specific population-based screening tests. Liver biopsy remains the gold standard for diagnosis as well as for grading and staging of the disease process but its precise role in the diagnostic conundrum continues to be debated.

REFERENCES

• 1 Marceau P, Biron S, Hould F S et al.. Liver pathology and the metabolic syndrome X in severe obesity.  J Clin Endocrinol Metab. 1999;  84 1513-1517
  CrossrefPubMedGoogle Scholar
• 2 Knobler H, Schattner A, Zhornicki T et al.. Fatty liver-an additional and treatable feature of the insulin resistance syndrome.  QJM. 1999;  92 73-79
  CrossrefPubMedGoogle Scholar
• 3 Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study.  Int J Obes. 1984;  8 97-106
  PubMedGoogle Scholar
• 4 Marchesini G, Brizi M, Morselli-Labate A M et al.. Association of nonalcoholic fatty liver disease with insulin resistance.  Am J Med. 1999;  107 450-455
  Google Scholar
• 5 Flegal K M, Carroll M D, Ogden C L, Johnson C L. Prevalence and trends in obesity among US adults, 1999-2000.  JAMA. 2002;  288 1723-1727
  CrossrefPubMedGoogle Scholar
• 6 Wanless I R, Lentz J S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.  Hepatology. 1990;  12 1106-1110
  CrossrefPubMedGoogle Scholar
• 7 Foster K J, Griffith A H, Dewbury K, Price C P, Wright R. Liver disease in patients with diabetes mellitus.  Postgrad Med J. 1980;  56 767-772
  PubMedGoogle Scholar
• 8 Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients.  Am J Med. 1979;  67 811-816
  CrossrefPubMedGoogle Scholar
• 9 Ludwig J, Viggiano T R, McGill D B, Oh B J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.  Mayo Clin Proc. 1980;  55 434-438
  PubMedGoogle Scholar
• 10 Bacon B R, Farahvash M J, Janney C G, Neuschwander-Tetri B A. Nonalcoholic steatohepatitis: an expanded clinical entity.  Gastroenterology. 1994;  107 1103-1109
  PubMedGoogle Scholar
• 11 Falck-Ytter Y, Younossi Z M, Marchesini G, McCullough A J. Clinical features and natural history of nonalcoholic steatosis syndromes.  Semin Liver Dis. 2001;  21 17-26
  Article in Thieme ConnectPubMedGoogle Scholar
• 12 Brunt E M. Nonalcoholic steatohepatitis: definition and pathology.  Semin Liver Dis. 2001;  21 3-16
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Younossi Z M, Gramlich T, Liu Y C et al.. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.  Mod Pathol. 1998;  11 560-565
  PubMedGoogle Scholar
• 14 Contos M J, Choudhury J, Mills A S, Sanyal A J. The histologic spectrum of nonalcoholic fatty liver disease.  Clin Liver Dis. 2004;  8 481-500
  PubMedGoogle Scholar
• 15 Powell E E, Cooksley W G, Hanson R, Searle J, Halliday J W, Powell L W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.  Hepatology. 1990;  11 74-80
  CrossrefPubMedGoogle Scholar
• 16 Loguercio C, De Girolomo V, de Sio I et al.. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.  J Hepatol. 2001;  35 568-574 , Erratum in: J Hepatol. 2002;  36 713
  PubMedGoogle Scholar
• 17 Mofrad P, Contos M J, Haque M et al.. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.  Hepatology. 2003;  37 1286-1292
  CrossrefPubMedGoogle Scholar
• 18 Neuschwander-Tetri B A, Caldwell S H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.  Hepatology. 2003;  37 1202-1219 , Erratum in: Hepatology. 2003;  38 536
  CrossrefPubMedGoogle Scholar
• 19 Franzese A, Vajro P, Argenziano A et al.. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.  Dig Dis Sci. 1997;  42 1428-1432
  CrossrefPubMedGoogle Scholar
• 20 Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan.  Jpn J Med. 1988;  27 142-149
  CrossrefPubMedGoogle Scholar
• 21 Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children.  Acta Paediatr. 1997;  86 238-241
  PubMedGoogle Scholar
• 22 Underwood Ground K E. Prevalence of fatty liver in healthy male adults accidentally killed.  Aviat Space Environ Med. 1984;  55 59-61
  PubMedGoogle Scholar
• 23 Oshibuchi M, Nishi F, Sato M, Ohtake H, Okuda K. Frequency of abnormalities detected by abdominal ultrasound among Japanese adults.  J Gastroenterol Hepatol. 1991;  6 165-168
  PubMedGoogle Scholar
• 24 Yano E, Tagawa K, Yamaoka K, Mori M. Test validity of periodic liver function tests in a population of Japanese male bank employees.  J Clin Epidemiol. 2001;  54 945-951
  CrossrefPubMedGoogle Scholar
• 25 Bellentani S, Saccoccio G, Masutti F et al.. Prevalence of and risk factors for hepatic steatosis in Northern Italy.  Ann Intern Med. 2000;  132 112-117
  PubMedGoogle Scholar
• 26 Shen L, Fan J G, Shao Y et al.. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.  World J Gastroenterol. 2003;  9 1106-1110
  PubMedGoogle Scholar
• 27 Clark J M, Brancati F L, Diehl A M. The prevalence and etiology of elevated aminotransferase levels in the United States.  Am J Gastroenterol. 2003;  98 960-967
  CrossrefPubMedGoogle Scholar
• 28 Galambos J T, Wills C E. Relationship between 505 paired liver tests and biopsies in 242 obese patients.  Gastroenterology. 1978;  74 1191-1195
  PubMedGoogle Scholar
• 29 Nomura F, Ohnishi K, Satomura Y et al.. Liver function in moderate obesity-study in 534 moderately obese subjects among 4613 male company employees.  Int J Obes. 1986;  10 349-354
  PubMedGoogle Scholar
• 30 Baldridge A D, Perez-Atayde A R, Graeme-Cook F, Higgins L, Lavine J E. Idiopathic steatohepatitis in childhood: a multicenter retrospective study.  J Pediatr. 1995;  127 700-704
  PubMedGoogle Scholar
• 31 Teli M R, James O F, Burt A D, Bennett M K, Day C P. The natural history of nonalcoholic fatty liver: a follow-up study.  Hepatology. 1995;  22 1714-1719
  CrossrefPubMedGoogle Scholar
• 32 Matteoni C A, Younossi Z M, Gramlich T, Boparai N, Liu Y C, McCullough A J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.  Gastroenterology. 1999;  116 1413-1419
  CrossrefPubMedGoogle Scholar
• 33 Ruhl C E, Everhart J E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.  Gastroenterology. 2003;  124 71-79
  CrossrefPubMedGoogle Scholar
• 34 Flegal K M, Carroll M D, Kuczmarski R J, Johnson C L. Overweight and obesity in the United States: prevalence and trends, 1960-1994.  Int J Obes Relat Metab Disord. 1998;  22 39-47
  CrossrefPubMedGoogle Scholar
• 35 Caldwell S H, Harris D M, Patrie J T, Hespenheide E E. Is NASH underdiagnosed among African Americans?.  Am J Gastroenterol. 2002;  97 1496-1500
  CrossrefPubMedGoogle Scholar
• 36 Ruhl C E, Everhart J E. Epidemiology of nonalcoholic fatty liver.  Clin Liver Dis. 2004;  8 501-519
  CrossrefPubMedGoogle Scholar
• 37 Struben V M, Hespenheide E E, Caldwell S H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.  Am J Med. 2000;  108 9-13
  PubMedGoogle Scholar
• 38 Lee J H, Reed D R, Price R A. Familial risk ratios for extreme obesity: implications for mapping human obesity genes.  Int J Obes Relat Metab Disord. 1997;  21 935-940
  CrossrefPubMedGoogle Scholar
• 39 Trevisan R, Vedovato M, Tiengo A. The epidemiology of diabetes mellitus.  Nephrol Dial Transplant. 1998;  13(suppl 8) 2-5
  PubMedGoogle Scholar
• 40 Castellano G, Garfia C, Gomez-Coronado D et al.. Diffuse fatty liver in familial heterozygous hypobetalipoproteinemia.  J Clin Gastroenterol. 1997;  25 379-382
  CrossrefPubMedGoogle Scholar
• 41 Ogata H, Akagi K, Baba M et al.. Fatty liver in a case with heterozygous familial hypobetalipoproteinemia.  Am J Gastroenterol. 1997;  92 339-342
  PubMedGoogle Scholar
• 42 Kagimoto T, Higaki T, Nagata K, Morino Y, Takatsuki K. An interesting syndrome of hemolytic anemia, degeneration of the liver and diabetes associated with a high red cell Mg-ATPase, detected by 31P NMR spectroscopy.  NMR Biomed. 1989;  2 93-97
  PubMedGoogle Scholar
• 43 Angulo P, Keach J C, Batts K P, Lindor K D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.  Hepatology. 1999;  30 1356-1362
  CrossrefPubMedGoogle Scholar
• 44 Lyznicki J M, Young D C, Riggs J A, Davis R M. Obesity: assessment and management in primary care.  Am Fam Physician. 2001;  63 2185-2196
  PubMedGoogle Scholar
• 45 Lakka H M, Laaksonen D E, Lakka T A et al.. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.  JAMA. 2002;  288 2709-2716
  CrossrefPubMedGoogle Scholar
• 46 Pi-Sunyer F X. The obesity epidemic: pathophysiology and consequences of obesity.  Obes Res. 2002;  10(suppl 2) 97S-104S
  CrossrefPubMedGoogle Scholar
• 47 George D K, Goldwurm S, MacDonald G A et al.. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.  Gastroenterology. 1998;  114 311-318
  CrossrefPubMedGoogle Scholar
• 48 Younossi Z M, Gramlich T, Bacon B R et al.. Hepatic iron and nonalcoholic fatty liver disease.  Hepatology. 1999;  30 847-850
  CrossrefPubMedGoogle Scholar
• 49 Bonkovsky H L, Jawaid Q, Tortorelli K et al.. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.  J Hepatol. 1999;  31 421-429
  CrossrefPubMedGoogle Scholar
• 50 Noguchi H, Tazawa Y, Nishinomiya F, Takada G. The relationship between serum transaminase activities and fatty liver in children with simple obesity.  Acta Paediatr Jpn. 1995;  37 621-625
  PubMedGoogle Scholar
• 51 Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair K S. Apolipoprotein synthesis in nonalcoholic steatohepatitis.  Hepatology. 2002;  35 898-904
  CrossrefPubMedGoogle Scholar
• 52 Clark J M, Brancati F L, Diehl A M. Nonalcoholic fatty liver disease.  Gastroenterology. 2002;  122 1649-1657
  CrossrefPubMedGoogle Scholar
• 53 Prati D, Taioli E, Zanella A et al.. Updated definitions of healthy ranges for serum alanine aminotransferase levels.  Ann Intern Med. 2002;  137 1-10
  CrossrefPubMedGoogle Scholar
• 54 Garcia-Monzon C, Martin-Perez E, Iacono O L et al.. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity.  J Hepatol. 2000;  33 716-724
  CrossrefPubMedGoogle Scholar
• 55 Daniel S, Ben M en, achem T, Vasudevan G, Ma C K, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.  Am J Gastroenterol. 1999;  94 3010-3014
  CrossrefPubMedGoogle Scholar
• 56 Skelly M M, James P D, Ryder S D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.  J Hepatol. 2001;  35 195-199
  CrossrefPubMedGoogle Scholar
• 57 Lee R G. Nonalcoholic steatohepatitis: a study of 49 patients.  Hum Pathol. 1989;  20 594-598
  CrossrefPubMedGoogle Scholar
• 58 Diehl A M, Goodman Z, Ishak K G. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury.  Gastroenterology. 1988;  95 1056-1062
  PubMedGoogle Scholar
• 59 Tajiri K, Takenawa H, Yamaoka K, Yamane M, Marumo F, Sato C. Nonalcoholic steatohepatitis masquerading as autoimmune hepatitis.  J Clin Gastroenterol. 1997;  25 538-540
  CrossrefPubMedGoogle Scholar
• 60 Saadeh S, Younossi Z M, Remer E M et al.. The utility of radiological imaging in nonalcoholic fatty liver disease.  Gastroenterology. 2002;  123 745-750
  CrossrefPubMedGoogle Scholar
• 61 Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast.  Tohoku J Exp Med. 1983;  139 43-50
  PubMedGoogle Scholar
• 62 Saverymuttu S H, Joseph A E, Maxwell J D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis.  Br Med J (Clin Res Ed). 1986;  292 13-15
  CrossrefPubMedGoogle Scholar
• 63 Mathiesen U L, Franzen L E, Aselius H et al.. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.  Dig Liver Dis. 2002;  34 516-522
  CrossrefPubMedGoogle Scholar
• 64 Mendler M H, Bouillet P, Le Sidaner A et al.. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload.  J Hepatol. 1998;  28 785-794
  CrossrefPubMedGoogle Scholar
• 65 Bydder G M, Chapman R W, Harry D, Bassan L, Sherlock S, Kreel L. Computed tomography attenuation values in fatty liver.  J Comput Tomogr. 1981;  5 33-35
  PubMedGoogle Scholar
• 66 Piekarski J, Goldberg H I, Royal S A, Axel L, Moss A A. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease.  Radiology. 1980;  137 727-729
  PubMedGoogle Scholar
• 67 Ducommun J C, Goldberg H I, Korobkin M, Moss A A, Kressel H Y. The relation of liver fat to computed tomography numbers: a preliminary experimental study in rabbits.  Radiology. 1979;  130 511-513
  PubMedGoogle Scholar
• 68 Galambos J T. Natural history of alcoholic hepatitis 3. Histological changes.  Gastroenterology. 1972;  63 1026-1035
  PubMedGoogle Scholar
• 69 Jacobs J E, Birnbaum B A, Shapiro M A et al.. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT.  AJR Am J Roentgenol. 1998;  171 659-664
  PubMedGoogle Scholar
• 70 Johnston R J, Stamm E R, Lewin J M, Hendrick R E, Archer P G. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements.  Abdom Imaging. 1998;  23 409-415
  CrossrefPubMedGoogle Scholar
• 71 Outwater E K, Blasbalg R, Siegelman E S, Vala M. Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1. 5 T: techniques and diagnostic importance.  Radiographics. 1998;  18 1465-1480
  PubMedGoogle Scholar
• 72 Longo R, Pollesello P, Ricci C et al.. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis.  J Magn Reson Imaging. 1995;  5 281-285
  PubMedGoogle Scholar
• 73 Sorbi D, McGill D B, Thistle J L, Therneau T M, Henry J, Lindor K D. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities.  Am J Gastroenterol. 2000;  95 3206-3210
  PubMedGoogle Scholar
• 74 Reid A L, Webb G R, Hennrikus D, Fahey P P, Sanson-Fisher R W. Detection of patients with high alcohol intake by general practitioners.  Br Med J (Clin Res Ed). 1986;  293 735-737
  PubMedGoogle Scholar
• 75 Lewis K O, Paton A. ABC of alcohol: tools of detection.  Br Med J (Clin Res Ed). 1981;  283 1531-1532
  PubMedGoogle Scholar
• 76 Salaspuro M. Use of enzymes for the diagnosis of alcohol-related organ damage.  Enzyme. 1987;  37 87-107
  PubMedGoogle Scholar
• 77 Nalpas B, Vassault A, Le Guillou A et al.. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis.  Hepatology. 1984;  4 893-896
  PubMedGoogle Scholar
• 78 Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit.  Hepatology. 1986;  6 608-614
  PubMedGoogle Scholar
• 79 Storey E L, Anderson G J, Mack U, Powell L W, Halliday J W. Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion.  Lancet. 1987;  1 1292-1294
  PubMedGoogle Scholar
• 80 Contos M J, Cales W, Sterling R K et al.. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.  Liver Transpl. 2001;  7 363-373
  CrossrefPubMedGoogle Scholar
• 81 Drenick E J, Fisler J, Johnson D. Hepatic steatosis after intestinal bypass-prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition.  Gastroenterology. 1982;  82 535-548
  CrossrefPubMedGoogle Scholar
• 82 Drenick E J, Simmons F, Murphy J F. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass.  N Engl J Med. 1970;  282 829-834
  CrossrefPubMedGoogle Scholar
• 83 Luyckx F H, Desaive C, Thiry A et al.. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.  Int J Obes Relat Metab Disord. 1998;  22 222-226
  CrossrefPubMedGoogle Scholar
• 84 Dixon J B, Bhathal P S, O'Brien P E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.  Gastroenterology. 2001;  121 91-100
  CrossrefPubMedGoogle Scholar
• 85 Caldwell S H, Oelsner D H, Iezzoni J C, Hespenheide E E, Battle E H, Driscoll C J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.  Hepatology. 1999;  29 664-669
  CrossrefPubMedGoogle Scholar
• 86 Poonawala A, Nair S P, Thuluvath P J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.  Hepatology. 2000;  32 689-692
  CrossrefPubMedGoogle Scholar
• 87 Hui J M, Kench J G, Chitturi S et al.. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.  Hepatology. 2003;  38 420-427
  PubMedGoogle Scholar
• 88 Hilden M, Juhl E, Thomsen A C, Christoffersen P. Fatty liver persisting for up to 33 years. A follow-up of the inversen-roholm liver biopsy material.  Acta Med Scand. 1973;  194 485-489
  PubMedGoogle Scholar
• 89 Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.  Am J Gastroenterol. 1987;  82 650-654
  PubMedGoogle Scholar
• 90 Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease.  Dig Dis Sci. 1995;  40 1805-1815
  PubMedGoogle Scholar
• 91 Poynard T, Ratziu V, McHutchison J et al.. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.  Hepatology. 2003;  38 75-85
  CrossrefPubMedGoogle Scholar
• 92 Bressler B L, Guindi M, Tomlinson G, Heathcote J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.  Hepatology. 2003;  38 639-644
  PubMedGoogle Scholar
• 93 Rubbia-Brandt L, Quadri R, Abid K et al.. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.  J Hepatol. 2000;  33 106-115
  CrossrefPubMedGoogle Scholar
• 94 Moriya K, Yotsuyanagi H, Shintani Y et al.. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.  J Gen Virol. 1997;  78(Pt 7) 1527-1531
  PubMedGoogle Scholar
• 95 Fujie H, Yotsuyanagi H, Moriya K et al.. Steatosis and intrahepatic hepatitis C virus in chronic hepatitis.  J Med Virol. 1999;  59 141-145
  CrossrefPubMedGoogle Scholar
• 96 Shintani Y, Fujie H, Miyoshi H et al.. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.  Gastroenterology. 2004;  126 840-848
  CrossrefPubMedGoogle Scholar
• 97 Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.  J Hepatol. 2001;  34 428-434
  CrossrefPubMedGoogle Scholar
• 98 Fernandez-Miranda C, Castellano G, Guijarro C et al.. Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.  Am J Gastroenterol. 1998;  93 1901-1904
  PubMedGoogle Scholar
• 99 Wyatt J, Baker H, Prasad P, Gong Y Y, Millson C. Steatosis and fibrosis in patients with chronic hepatitis C.  J Clin Pathol. 2004;  57 402-406
  CrossrefPubMedGoogle Scholar
• 100 Hui J M, Sud A, Farrell G C et al.. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression.  Gastroenterology. 2003;  125 1695-1704
  CrossrefPubMedGoogle Scholar
• 101 Bugianesi E, Manzini P, D'Antico S et al.. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.  Hepatology. 2004;  39 179-187
  CrossrefPubMedGoogle Scholar
• 102 McCaughan G W. Recurrence of nonalcoholic steatohepatitis (NASH) post-liver transplantation.  Liver Transpl Surg. 1997;  3 683
  PubMedGoogle Scholar
• 103 Molloy R M, Komorowski R, Varma R R. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation.  Liver Transpl Surg. 1997;  3 177-178
  CrossrefPubMedGoogle Scholar
• 104 Carson K, Washington M K, Treem W R, Clavien P A, Hunt C M. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.  Liver Transpl Surg. 1997;  3 174-176
  CrossrefPubMedGoogle Scholar
• 105 Kim W R, Poterucha J J, Porayko M K, Dickson E R, Steers J L, Wiesner R H. Recurrence of nonalcoholic steatohepatitis following liver transplantation.  Transplantation. 1996;  62 1802-1805
  PubMedGoogle Scholar
• 106 D'Souza-Gburek S M, Batts K P, Nikias G A, Wiesner R H, Krom R A. Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb.  Liver Transpl Surg. 1997;  3 23-27
  PubMedGoogle Scholar
• 107 Andersen T, Christoffersen P, Gluud C. The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study.  Int J Obes. 1984;  8 107-115
  PubMedGoogle Scholar
• 108 Kern W H, Payne J H, Dewind L T. Hepatic changes after small-intestinal bypass for morbid obesity.  Am J Clin Pathol. 1974;  61 763-768
  PubMedGoogle Scholar
• 109 White J J, Moxley RT I II, Pozefsky T, Lockwood D H. Transient kwaskiorkor: a cause of fatty liver following small bowel bypass.  Surgery. 1974;  75 829-840
  PubMedGoogle Scholar
• 110 Halloran L G, Hutcher N E, Levinson S A, Schatzki P F, Hume D M. Morphology of the liver before and after intestinal bypass for morbid obesity.  Surg Forum. 1974;  25 359-361
  PubMedGoogle Scholar
• 111 Marubbio Jr A T, Buchwald H, Schwartz M Z, Varco R. Hepatic lesions of central pericellular fibrosis in morbid obesity, and after jejunoileal bypass.  Am J Clin Pathol. 1976;  66 684-691
  PubMedGoogle Scholar
• 112 Baddeley R M. Results of jejuno-ileostomy for gross refractory obesity.  Br J Surg. 1976;  63 801-806
  PubMedGoogle Scholar
• 113 Salmon P A, Reedyk L. Fatty metamorphosis in patients with jejunoileal bypass.  Surg Gynecol Obstet. 1975;  141 75-84
  PubMedGoogle Scholar
• 114 Griffen Jr W O, Young V L, Stevenson C C. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity.  Ann Surg. 1977;  186 500-509
  PubMedGoogle Scholar
• 115 Buckwalter J A. Clinical trial of jejunoileal and gastric bypass for the treatment of morbid obesity: four-year progress report.  Am Surg. 1980;  46 377-381
  PubMedGoogle Scholar
• 116 Ogden C L, Troiano R P, Briefel R R, Kuczmarski R J, Flegal K M, Johnson C L. Prevalence of overweight among preschool children in the United States, 1971 through 1994.  Pediatrics. 1997;  99 E1
  PubMedGoogle Scholar
• 117 Tominaga K, Kurata J H, Chen Y K et al.. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey.  Dig Dis Sci. 1995;  40 2002-2009
  PubMedGoogle Scholar
• 118 Rashid M, Roberts E A. Nonalcoholic steatohepatitis in children.  J Pediatr Gastroenterol Nutr. 2000;  30 48-53
  CrossrefPubMedGoogle Scholar
• 119 Sanyal A J. AGA technical review on nonalcoholic fatty liver disease.  Gastroenterology. 2002;  123 1705-1725
  CrossrefPubMedGoogle Scholar
• 120 Silverman E M, Sapala J A, Appelman H D. Regression of hepatic steatosis in morbidly obese persons after gastric bypass.  Am J Clin Pathol. 1995;  104 23-31
  PubMedGoogle Scholar
• 121 Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity.  Digestion. 1990;  47 208-214
  PubMedGoogle Scholar
• 122 Pinto H C, Baptista A, Camilo M E, Valente A, Saragoca A, de Moura M C. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.  Dig Dis Sci. 1996;  41 172-179
  PubMedGoogle Scholar
• 123 Laurin J, Lindor K D, Crippin J S et al.. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.  Hepatology. 1996;  23 1464-1467
  CrossrefPubMedGoogle Scholar

Arun J SanyalM.D. 

Virginia Commonwealth University

MCV Box 980711, Richmond, VA 23298-0711

Email: ajsanyal@hsc.vcu.edu